Abstract
The biomedical network is becoming a fundamental tool to represent sophisticated biosystems, while Random Walk (RW) models on it are becoming a sharp sword to address such challenging issues as gene function annotation, drug target identification, and disease biomarker recognition. Recently, numerous random walk models have been proposed and applied to biomedical networks. Due to good performances, the random walk is attracting increasing attentions from multiple communities. In this survey, we firstly introduced various random walk models, with emphasis on the PageRank and the random walk with restart. We then summarized applications of the random work RW on the biomedical networks from the graph learning point of view, which mainly included node classification, link prediction, cluster/community detection, and learning representation of the node. We discussed briefly its limitation and existing issues also.
Keywords: Random walk, network embedding, link prediction, clustering, node classification, node representation.
Current Proteomics
Title:Random Walks on Biomedical Networks
Volume: 18 Issue: 5
Author(s): Guiyang Zhang, Pan Wang, You Li and Guohua Huang*
Affiliation:
- Provincial Key Laboratory of Informational Service for Rural Area of Southwestern Hunan, Shaoyang University, Shaoyang 422000,China
Keywords: Random walk, network embedding, link prediction, clustering, node classification, node representation.
Abstract: The biomedical network is becoming a fundamental tool to represent sophisticated biosystems, while Random Walk (RW) models on it are becoming a sharp sword to address such challenging issues as gene function annotation, drug target identification, and disease biomarker recognition. Recently, numerous random walk models have been proposed and applied to biomedical networks. Due to good performances, the random walk is attracting increasing attentions from multiple communities. In this survey, we firstly introduced various random walk models, with emphasis on the PageRank and the random walk with restart. We then summarized applications of the random work RW on the biomedical networks from the graph learning point of view, which mainly included node classification, link prediction, cluster/community detection, and learning representation of the node. We discussed briefly its limitation and existing issues also.
Export Options
About this article
Cite this article as:
Zhang Guiyang , Wang Pan , Li You and Huang Guohua *, Random Walks on Biomedical Networks, Current Proteomics 2021; 18 (5) . https://dx.doi.org/10.2174/1570164617999200731001544
DOI https://dx.doi.org/10.2174/1570164617999200731001544 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroprotective Role of Agmatine in Neurological Diseases
Current Neuropharmacology Radiofluorinated Carbohydrates for Positron Emission Tomography
Current Topics in Medicinal Chemistry Insights into the Molecular Mechanism of hERG1 Channel Activation and Blockade by Drugs
Current Medicinal Chemistry Novel Histone Deacetylase Inhibitors for the Treatment of Pediatric Brain Tumors
Central Nervous System Agents in Medicinal Chemistry Reprogrammed Metabolism of Cancer Cells as a Potential Therapeutic Target
Current Pharmaceutical Design The Safety, Tolerability, Pharmacokinetics and Cognitive Effects of GSK239512, a Selective Histamine H<sub>3</sub> Receptor Antagonist in Patients with Mild to Moderate Alzheimer’s Disease: A Preliminary Investigation
Current Alzheimer Research MMP-9 Inhibitors in the Brain: Can Old Bullets Shoot New Targets?
Current Pharmaceutical Design 1,2,4-Triazine Analogs as Novel Class of Therapeutic Agents
Mini-Reviews in Medicinal Chemistry N-acetylcysteine Versus Placebo for Treating Nail Biting, a Double Blind Randomized Placebo Controlled Clinical Trial
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Current Methods in the Automatic Tissue Segmentation of 3D Magnetic Resonance Brain Images
Current Medical Imaging Biology of Heme: Drug Interactions and Adverse Drug Reactions with CYP450
Current Topics in Medicinal Chemistry Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches
Current Medicinal Chemistry Intrahippocampal Amyloid-β (1-40) Injections Injure Medial Septal Neurons in Rats
Current Alzheimer Research Increased CRMP2 Phosphorylation is Observed in Alzheimers Disease; Does this Tell us Anything About Disease Development?
Current Alzheimer Research Differences in Relative Levels of 88 microRNAs in Various Regions of the Normal Adult Human Brain
MicroRNA ABC Pumps and Their Role in Active Drug Transport
Current Topics in Medicinal Chemistry Adiponectin and its Role in Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Galanin: A Novel Therapeutic Target for Depression, Anxiety Disorders and Drug Addiction?
CNS & Neurological Disorders - Drug Targets Hepatic Effects of Duloxetine-I: Non-Clinical and Clinical Trial Data
Current Drug Safety